Left atrial thrombus formation early after mitral valve replacement.
Canivet
Jean-Luc
JL
Department of General Intensive Care, University Hospital of Liége, Liége, Belgium. Jean-Luc.Canivet@chu.ulg.ac.be
Yans
Thierry
T
Roediger
Laurence
L
Radermecker
Marc Albert
MA
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D002303:Cardiac Output, Low / Q000209:etiology; D015150:Echocardiography, Doppler / Q000379:methods; D017548:Echocardiography, Transesophageal / Q000379:methods; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging; D006331:Heart Diseases / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000209:etiology; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D011183:Postoperative Complications / Q000175:diagnosis* / Q000209:etiology; D013927:Thrombosis / Q000175:diagnosis* / Q000209:etiology; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin; D000638:Amiodarone